Page 94#21. DMSO (dimethyl sulphoxide)
Here’s an amazing substance that was once hailed on mainstream TV (“60
Minutes”) as a miracle and the NY Times said, in a lead editorial published April
3, 1965, that “DMSO is... the closest thing to a wonder produced in the 1960s.”
Yet DMSO is now largely forgotten, since it is not hyped by Big Pharma, the way
they do for drugs.
DMSO is an organic, sulfur-rich substance found in the woody part of trees. It
was first discovered by a Russian researcher in 1866. It absorbs easily and a
drop placed on the skin will be sucked in almost instantly. Over 12,000 modern
papers have studied its amazing properties.
Among other properties, DMSO is a tremendous pain reliever. But it also has
a real part to play in fighting cancer the “chemical route”. It seems to protect
the body from the ravages of chemo agents, notably cyclophosphamide, and at
the same time can persuade many types of cancer cells to start behaving more
normally. It relieves pain noticeably and helps the patients normalize the sickly
feeling so obvious with cancer.
Studies carried out by Jorge Cornejo Garrido MD at the military hospital in
Santiago, Chile, convince me.
DMSO performs best with the lymphoma group of cancers. Note that it
doesn’t actually kill tumor cells, so much as turn them back to well-behaved
counterparts.
Several studies of this group of compounds, called polar solvents, have shown
this tendency to be very pronounced. This could be called tumor maturation
therapy, since it turns wild, uncontrolled “young” or undifferentiated cells into
sensible citizens of the body.
Why doesn’t the FDA approve it? Well at first they admitted this was such a
versatile substance with so many applications, they simply didn’t have enough
staff to evaluate it. Quite likely too, they cannot cope with the idea of a
compound sold commercially as a solvent can also have drug status.
But you know the FDA is not there for your protection but to protect the drug
industry. Such a cheap, safe adjuvant to therapy simply cannot be released to
the public. So they complain about lack of safety reports (there are hundreds
of good papers) and lack of patient experience (there are over 100,000 patient
success reports of safety, which the FDA commissioners simply ignore in their
bleatings).